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Innervation Patterns in the Renal Artery Ostium May Limit the Efﬁcacy of
Endovascular Radiofrequency Ablation
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Background: Unconﬁrmed anecdotal evidence suggests that the superior aspect of the
renal artery ostium is an attractive target for endovascular ablation.
Methods: Nerve and ganglion distribution was characterized in 16 renal arteries at 3
discrete distances from the aorta (Fig 1). RF ablation was performed in the renal
ostium of another 8 arteries using a prototype renal/crescent multi-electrode RF
catheter (Biosense Webster, CA) & treatments were conﬁrmed by angiography. Renal
norepinephrine (NEPI) levels were correlated with ablation zone geometries & nerve
and ganglia injury 7d post denervation.
Results: Nerves & ganglia were more abundant but more distant from the lumen at
locations closest to the aorta (Fig 1). At all 3 distances from the aorta, nerves and ganglia
were distributed across all 4 quadrants. Efﬁcacy was observed in 1 of 8 treated arteries
where ablation area was 99.1mm2 & involved all 4 quadrants at a maximal depth of
9.1mm affecting 50% of nerves & reducing NEPI (37ng/g). In the other 7 arteries, no
efﬁcacy was observed, fewer than 20% of the nerves were affected, the ablation areas
were smaller (16.210.9mm2) & present in only 1-2 quadrants at maximal depths of
3.82.7mm, and renal NEPI levels remained at baseline (620-991ng/g). Half of ablation
zones did not contain ganglia, and the rest only 1 or 2 ganglia.Conclusions: Renal denervation therapies which speciﬁcally target the renal ostium
must account for the unique anatomy and treatments localized to the superior aspect of
the ostium alone will likely have limited added beneﬁt as nerves are present in all
quadrants.
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Background: Abipolarmulti-electrode 7 Fr-compatible balloon catheter radiofrequency
(RF) renal denervation system (Vessix, Boston Scientiﬁc, Natick, MA) with short pro-
cedure time was evaluated in a preclinical safety study in a domestic swine model.
Methods: Renal arteries of 27 swine received whole-artery treatment with over-
lapping treatments in the proximal 12 mm to mimic balloon overlap. Each of 3 his-
topathology cohorts (30, 90, 180 day follow-ups) had 4 RF-treated and 3 sham-treated
(no RF energy delivered) animals; response of artery and surrounding nerves to
bilateral treatment was examined (42 arteries). Scanning electron microscopy (SEM)
was used to examine the renal artery ﬂow surface for endothelialization in an addi-
tional 6 pigs (3 at each of 30 and 90 days: 12 arteries) following unilateral whole-
artery treatment with proximal overlap: RF on one side and sham on the other. Power
wasw1 watt, treatment duration 30 seconds, target temperature 68C. Histology was
done on all 54 kidneys and assessment for off-target injury was done in all 27 swine.
Results: One pig died due to spiral colon torsion unrelated to the device at 131 days,
resulting in 6 arteries evaluated for the 180 day cohort. Renal artery injury was
transmural and segmental, typically involving 30-60% of the circumference and
demonstrating overlying nerve injury and associated segmental neointimal hyperplasia
which was hemodynamically trivial (maximum stenosis 17.7% in any section).
Healing of necrotic arterial media was by replacement ﬁbrosis, essentially complete at
90 days and unchanged at 180 days. Overlying nerves also became ﬁbrotic with no
evidence of regeneration at 180 days by conventional histology. Endothelialization
was focally incomplete at 30 days but conﬂuent at 90 days. Sham-treated arteries
showed only focal mechanical injury also seen with RF treatment. Kidney histologyJACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/Nedemonstrated no injury and there was also no injury to renal veins, ureters, adrenal
glands, psoas muscles, peritoneum or intestine.
Conclusions: Safety of the Boston Scientiﬁc Vessix Renal Denervation System in 7F
conﬁguration was demonstrated for both single and overlap treatment.
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Background: Renal Denervation (RDN) is an effective treatment for resistant hy-
pertension. The procedure was done ﬁrst with a single electrode catheter creating
multiple intentionally spaced lesions. The catheter delivers 4-6 radiofrequency (RF)
ablations at points distributed along the length of the renal artery. The procedure
requires rotation and pull-back of the catheter between each hit. Second generation
devices enable multiple simultaneous ablations at different points, allowing a single
hit. RF is applied with pre-programmed time and intensity. The system provides same
power regardless of catheter size eliminating the need for adjustment of the level. This
gives a more predictable lesion pattern with single hit and a shorter time. This may
reduce the risk of overheating and clot formation during RF delivery. The effect of
RDN on renal blood ﬂow (RBF) and the safety of the two generations of devices
haven’t been compared. We report the effect of those devices on RBF by using the
method of renal frame count (RFC).
Methods: We studied the (RBF) before and after RDN by counting the numbers of
frames (fr)on the renal angiogram from a beginning fr to an end fr. Fr1 is the fr that
shows both edges of the ostium of the renal artery immediately after contrast injection.
The end fr the fr which shows the contrast when it has reached the lateral edge of the
renal cortex. RFC was calculated before and immediately after RDN in 10 cases done
using 1st generation device. The results were compared with another 10 cases done
using 2nd generation device.
Results: The mean RFC was 9.28 fr before RDN and increased to 13.71 fr after RDN
in the cases that used 1st generation device (p< 0.001) suggesting slower (RBF) after
RDN. The mean RFC was 9.44 fr before RDN and remained unchanged after the
procedure in the cases that used 2nd generation device (p¼0.759) suggesting no
signiﬁcant changes in (RBF) after the procedure.
Conclusions: 1st generation device causes signiﬁcant increase in RFC reﬂecting
deterioration in RBF when compared with 2nd generation. This can be explained by
distal embolization due to catheter manipulation and micro clots formation from blood
ovweheating due to loss of direct contact with intima.New Devices and Innovation
Washington Convention Center, Lower Level, Hall A
Saturday, September 13, 2014, 5:00 PM–7:00 PM
Abstract nos: 428-459
TCT-428
First Percutaneous Transluminal Caval ﬂow Restriction in a Patient with
Congestive Heart Failure
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Background: So far, preload reduction in patients with Congestive Heart Failure
(CHF) is performed by the use of high potency diuretics. We have previously reported
that a Dynamic Stenosis of Inferior Vena Cava (IVC) associated with beneﬁcial he-
modynamic changes occurs, in some patients with CHF. Here, we are reporting one
case of intermittent preload reduction by the use of an inﬂated balloon placed in the
high IVC and guided by respiratory phases resulting in total occlusion during inspi-
ration and subtotal occlusion during expiration.
Methods: 66 years-old Female patient with ischemic heart failure with severe left
ventricular (LV) dysfunction (EF 39%), severe diastolic dysfunction with high LV
ﬁlling pressure, NYHA class 2B, angina, scheduled for coronary angiogram. The
patient was screened and enrolled in our caval ﬂow protocol trial. An IVC balloon
catheter for venous occlusion was introduced via right femoral vein, and was inﬂated
up to 10 mm before the drainage of the Hepatic veins in the IVC. The IVC velocity
was measured at 2 cm from the right atrium and caval ﬂow velocity was 1.08 m/s, and
then was inﬂated up to 13 to 14 mm achieving caval ﬂow velocity up to 1.28 m/sec.
The balloon remained inﬂated for 25 min.
Results: Right heart pressures and echocardiographic measurements showed: 44%
reduction in pulmonary capillary pressure, 38% right ventricular pressure, and 60%
reduction of the right atrium pressure compared with baseline. The LV diastolic
diameter was reduced by 8% and systolic diameter decreased 18%, Ee’ was reducedw Devices and Innovation B125
